Artificial intelligence is no longer just spotting tumors a little faster than humans. In study after study, machine learning systems are uncovering hidden patterns in cancer data that even veteran ...

New research presented during the 2024 San Antonio Breast Cancer Symposium (SABCS) reveals a new machine learning model that could change the way metastatic breast cancer is treated in the future. By ...

A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR ...

The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, ...

Presentations showcase the power of omnimodal profiling to identify predictive immune signatures, comprehensively profile the tumor microenvironment and reveal novel therapeutic targets for optimized ...

SAN ANTONIO – A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with ...

Abbreviations: Carbo or cis, carboplatin or cisplatin; Cyclo, cyclophosphamide; Doxo, doxorubicin; ER, estrogen receptor; Her (per), pertuzumab; Her (TRAS ...

Enhancing prognostic accuracy in lung cancer brain metastases through histopathologic feature integration and AI-based image analysis. Development and validation of an AI model for predicting germline ...

TrialTranslator uncovers the survival gap for high-risk patients and offers a path to better cancer research. Study: Evaluating generalizability of oncology trial results to real-world patients using ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...